NCT03046329
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,082 public trials
2,050 recruiting studies
Lymphoproliferative Disorders trial results
NCT00004009
- Conditions
- Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +23 more
- Locations
-
- University of Iowa College of Medicine Iowa City, Iowa, United States
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
- University of Rochester Cancer Center Rochester, New York, United States
NCT01541644
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- University of Maryland Marlene & Stewart Greenebaum Cancer Center Baltimore, Maryland, United States
Completed
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
NCT01660776
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +26 more
- Locations
-
- Rennes EFS Rennes, Brittanny, France
- Rennes University Hospital Rennes, Brittanny, France
- Institut Paoli Calmette Marseille, France
- Montpellier University Hospital Montpellier, France
NCT02006485
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
- Locations
-
- TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
- TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States
- TG Therapeutics Investigational Trial Site Duarte, California, United States
- TG Therapeutics Investigational Trial Site Atlanta, Georgia, United States
NCT00003397
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
- Locations
-
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
NCT00046852
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00006350
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +51 more
- Locations
-
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
NCT00106431
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- UCLA Jonsson Cancer Center Los Angeles, California, United States
- Stanford Comprehensive Cancer Center Stanford, California, United States
- Boston Medical Center Boston, Massachusetts, United States
- University of Pennsylvania Abrahamson Cancer Center Philadelphia, Pennsylvania, United States
NCT00105001
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States